Hologic, Inc.Hologic, Inc.Hologic, Inc.

Hologic, Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪12.22 B‬EUR
2.06EUR
‪709.08 M‬EUR
‪3.62 B‬EUR
‪220.46 M‬
Beta (1Y)
0.00
Employees (FY)
‪7.06 K‬
Change (1Y)
+73 +1.04%
Revenue / Employee (1Y)
Net income / Employee (1Y)

About Hologic, Inc.


CEO
Stephen P. MacMillan
Headquarters
Marlborough
Founded
1985
ISIN
US4364401012
FIGI
BBG000GPLF54
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focuses on women’s health and well-being through early detection and treatment. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment is involved in a portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology and treatment. The Diagnostics segment offers a range of products, which are used primarily to aid in the screening and diagnosis of human diseases. The GYN Surgical segment is involved in hysteroscopic endometrial ablation systems, tissue removal systems, fluid management systems, and laparoscopic tissue ablation systems and tools. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.

Check out other big names from the same industry as HO1.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
HOLX4588305
Hologic, Inc. 4.625% 01-FEB-2028
Yield to maturity
Maturity date
Feb 1, 2028
HOLX4587167
Hologic, Inc. 4.625% 01-FEB-2028
Yield to maturity
Maturity date
Feb 1, 2028
USU38284AF9
Hologic, Inc. 3.25% 15-FEB-2029
Yield to maturity
Maturity date
Feb 15, 2029

See all HO1 bonds 

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange Hologic, Inc. stocks are traded under the ticker HO1.
We've gathered analysts' opinions on Hologic, Inc. future price: according to them, HO1 price has a max estimate of 80.46 EUR and a min estimate of 55.64 EUR. Watch HO1 chart and read a more detailed Hologic, Inc. stock forecast: see what analysts think of Hologic, Inc. and suggest that you do with its stocks.
HO1 reached its all-time high on Feb 8, 2023 with the price of 80.63 EUR, and its all-time low was 7.36 EUR and was reached on Mar 10, 2009. View more price dynamics on HO1 chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track Hologic, Inc. financials in yearly and quarterly reports right on TradingView.
Hologic, Inc. is going to release the next earnings report on Nov 3, 2025. Keep track of upcoming events with our Earnings Calendar.
HO1 earnings for the last quarter are 0.92 EUR per share, whereas the estimation was 0.90 EUR resulting in a 1.52% surprise. The estimated earnings for the next quarter are 0.94 EUR per share. See more details about Hologic, Inc. earnings.
Hologic, Inc. revenue for the last quarter amounts to ‪869.11 M‬ EUR, despite the estimated figure of ‪857.75 M‬ EUR. In the next quarter, revenue is expected to reach ‪881.19 M‬ EUR.
HO1 net income for the last quarter is ‪165.45 M‬ EUR, while the quarter before that showed ‪−16.08 M‬ EUR of net income which accounts for ‪1.13 K‬% change. Track more Hologic, Inc. financial stats to get the full picture.
No, HO1 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 14, 2025, the company has ‪7.06 K‬ employees. See our rating of the largest employees — is Hologic, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Hologic, Inc. EBITDA is ‪1.06 B‬ EUR, and current EBITDA margin is 31.74%. See more stats in Hologic, Inc. financial statements.
Like other stocks, HO1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Hologic, Inc. stock right from TradingView charts — choose your broker and connect to your account.